Literature DB >> 17553067

A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'.

K Kozaka1, M Sasaki, T Fujii, K Harada, Y Zen, Y Sato, S Sawada, H Minato, O Matsui, Y Nakanuma.   

Abstract

AIMS: The histogenesis and biological behaviour of peripheral intrahepatic cholangiocarcinoma (peripheral CC) remain unclarified. The aim of this study was to examine the growth pattern of peripheral CC (24 cases) in comparison with hepatocellular carcinoma (HCC, 27 cases) and metastatic colorectal adenocarcinoma (MCA, 24 cases). METHODS AND
RESULTS: Tumour/surrounding liver borders were classified as: (i) fibrous encapsulation, (ii) compressive growth, and (iii) infiltrating replacement. Nineteen of 24 peripheral CCs showed (iii), whereas 23 of 27 HCCs showed (i) and 17 of 24 MCAs showed (ii). In (iii), carcinoma cells infiltrated the surrounding liver without compression, and hepatic supporting vascular structures such as portal tracts were secondarily incorporated into the tumour. In (i) and (ii), the surrounding liver was compressed and no or few portal tracts were incorporated within the tumour. Fifteen of 24 peripheral CCs were composed of carcinoma cells resembling reactive bile ductules and these cells were positive for neural cell adhesion molecule (NCAM), a marker of proliferating bile ductules. The remaining nine peripheral CCs were composed of ordinary adenocarcinoma and negative for NCAM.
CONCLUSIONS: A subgroup of peripheral CCs with an infiltrating replacement growth pattern resembles reactive bile ductules and expresses NCAM. 'Bile ductular carcinoma' may be a better term for this subgroup.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17553067     DOI: 10.1111/j.1365-2559.2007.02735.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  22 in total

Review 1.  Intrahepatic cholangiocarcinoma and cholangiolocellular carcinoma in cirrhosis and chronic viral hepatitis.

Authors:  Shun-ichi Ariizumi; Masakazu Yamamoto
Journal:  Surg Today       Date:  2014-09-25       Impact factor: 2.549

2.  Apical membrane expression of distinct sulfated glycans represents a novel marker of cholangiolocellular carcinoma.

Authors:  Hitomi Hoshino; Makoto Ohta; Makoto Ito; Kenji Uchimura; Yasuhiro Sakai; Takeshi Uehara; Shulin Low; Mana Fukushima; Motohiro Kobayashi
Journal:  Lab Invest       Date:  2016-10-17       Impact factor: 5.662

3.  Claudin-18 in biliary neoplasms. Its significance in the classification of intrahepatic cholangiocarcinoma.

Authors:  Aya Shinozaki; Junji Shibahara; Naohiro Noda; Mariko Tanaka; Taku Aoki; Norihiro Kokudo; Masashi Fukayama
Journal:  Virchows Arch       Date:  2011-05-24       Impact factor: 4.064

4.  Pathological classification of intrahepatic cholangiocarcinoma based on a new concept.

Authors:  Yasuni Nakanuma; Yasunori Sato; Kenichi Harada; Motoko Sasaki; Jing Xu; Hiroko Ikeda
Journal:  World J Hepatol       Date:  2010-12-27

5.  Multistep carcinogenesis of perihilar cholangiocarcinoma arising in the intrahepatic large bile ducts.

Authors:  Yasuni Nakanuma; Motoko Sasaki; Yasunori Sato; Xiangshan Ren; Hiroko Ikeda; Kenichi Harada
Journal:  World J Hepatol       Date:  2009-10-31

6.  Clinicopathologic study of mixed adenoneuroendocrine carcinomas of hepatobiliary organs.

Authors:  Kenichi Harada; Yasunori Sato; Hiroko Ikeda; Hsu Maylee; Saya Igarashi; Atsushi Okamura; Shinji Masuda; Yasuni Nakanuma
Journal:  Virchows Arch       Date:  2012-02-23       Impact factor: 4.064

Review 7.  Early detection of intrahepatic cholangiocarcinoma.

Authors:  Mami Hamaoka; Kazuto Kozaka; Osamu Matsui; Takahiro Komori; Takashi Matsubara; Norihide Yoneda; Kotaro Yoshida; Dai Inoue; Azusa Kitao; Wataru Koda; Toshifumi Gabata; Satoshi Kobayashi
Journal:  Jpn J Radiol       Date:  2019-08-01       Impact factor: 2.374

8.  Claudins-4 and -7 might be valuable markers to distinguish hepatocellular carcinoma from cholangiocarcinoma.

Authors:  Yusuke Ono; Yutaro Hiratsuka; Masaki Murata; Akira Takasawa; Rieko Fukuda; Masanori Nojima; Satoshi Tanaka; Makoto Osanai; Koichi Hirata; Norimasa Sawada
Journal:  Virchows Arch       Date:  2016-07-21       Impact factor: 4.064

Review 9.  Cholangiolocellular carcinoma with rapid progression initially showing abnormally elevated serum alfa-fetoprotein.

Authors:  Tomoaki Yoh; Tatsushi Kato; Yoshiaki Hirohata; Yuya Nakamura; Hiroyuki Nakayama; Ryuji Okamura
Journal:  Clin J Gastroenterol       Date:  2016-06-30

Review 10.  Models and molecular mechanisms of blood vessel co-option by cancer cells.

Authors:  Yu Zhang; Sarah Wang; Andrew C Dudley
Journal:  Angiogenesis       Date:  2019-10-18       Impact factor: 9.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.